Comparative studies on the human serum albumin binding of the clinically approved EGFR inhibitors gefitinib, erlotinib, afatinib, osimertinib and the investigational inhibitor KP2187

Dömötör Orsolya and Pelivan Karla and Borics Attila and Keppler Bernhard K. and Kowol Christian R. and Enyedy Éva Anna: Comparative studies on the human serum albumin binding of the clinically approved EGFR inhibitors gefitinib, erlotinib, afatinib, osimertinib and the investigational inhibitor KP2187.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 154. pp. 321-331. ISSN 0731-7085 (2018)

[thumbnail of Domotor_JPBA_2018.pdf]
Preview
Text
Domotor_JPBA_2018.pdf - Submitted Version

Download (1MB) | Preview
[thumbnail of EGFR_2018_Domotor_et_al_u.pdf]
Preview
Text
EGFR_2018_Domotor_et_al_u.pdf - Draft Version

Download (1MB) | Preview
Item Type: Article
Journal or Publication Title: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Date: 2018
Volume: 154
Page Range: pp. 321-331
ISSN: 0731-7085
Faculty/Unit: Faculty of Science and Informatics
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 3346922
DOI azonosító: https://doi.org/10.1016/j.jpba.2018.03.011
Date Deposited: 2019. Jul. 05. 15:09
Last Modified: 2019. Jul. 05. 15:11
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/16019
Web of Science® Times Cited: 12 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year